Macular Thickness in Subjective Memory Complaints and Mild Cognitive Impairment: A Non-Invasive Biomarker

References

• Mayeux R, Stern Y, Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011;7:137–152.
   PubMed Web of Science ®Google Scholar
• Takizawa C, Thompson PL, Van Walsem A, Faure C, Maier WC. Epidemiological and economic burden of Alzheimer’s disease: a systematic literature review of data across Europe and the United States of America. J Alzheimers Dis 2015;43:1271–1284.
   PubMed Web of Science ®Google Scholar
• Ikram MK, Cheung CY, Wong TY, Chen CPLH. Retinal pathology as biomarker for cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2012;83:917–922.
   PubMed Web of Science ®Google Scholar
• Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet 2006;368:387–403.
   PubMed Web of Science ®Google Scholar
• Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin Neurol Neurosurg 2011;113:523–526.
   PubMed Web of Science ®Google Scholar
• Levey A, Lah J, Goldstein F, Steenland K, Bliwise D. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer’s disease. Clin Ther 2006;28:991–1001.
   PubMed Web of Science ®Google Scholar
• Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–420.
   PubMed Web of Science ®Google Scholar
• Grundman M. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59–66.
   PubMed Web of Science ®Google Scholar
• Bermejo F. Demand for neurological services in Spain. Data for a more demanding future. Rev Neurol 1999;29:673–677.
   PubMed Web of Science ®Google Scholar
• Menéndez González M, Garcia-Fernández C, Antón González C, Calatayud MT, González González S, Blázquez Menes B. Memory loss: a reason for consultation. Neurologia 2005;20:390–394.
   PubMed Web of Science ®Google Scholar
• Mendes T, Ginó S, Ribeiro F, Guerreiro M, de Sousa G, Ritchie K, de Mendonça A. Memory complaints in healthy young and elderly adults: reliability of memory reporting. Aging Ment Health 2008;12:177–182.
   PubMed Web of Science ®Google Scholar
• Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints may announce dementia. Neurology 1996;46:121–125.
   PubMed Web of Science ®Google Scholar
• Rebolleda G, Muñoz-Negrete FJ. Optical coherence tomography, an inflection point in neuro-ophthalmology. Arch Soc Esp Oftalmol 2007;82:731–732.
   PubMedGoogle Scholar
• Carmen K, Chan M. The use of optical coherence tomography in neuro-ophthalmology. H K J Ophthalmol 2012;15:12–19.
   Google Scholar
• Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 2005;107:165–173.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin ES, Rojas B, Ramirez AI, de Hoz R, Salazar JJ, Yubero R, Gil P, Triviño A, Ramirez JM. Macular thickness as a potential biomarker of mild Alzheimer’s disease. Ophthalmology 2014;121:1149–1151.e3.
   Web of Science ®Google Scholar
• Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, Venketasubramanian N, Yap P, Seow D, Chen CLH, Wong TY. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 2015;45:45–56.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Cockrell JR, Folstein MF, Mini-Mental State Examination (MMSE). Psychopharmacol Bull 1988;24(4):689–92
   PubMed Web of Science ®Google Scholar
• Sallam K, Amr M. The use of the mini-mental state examination and the clock-drawing test for dementia in a tertiary hospital. J Clin Diagn Res 2013;7:484–488.
   PubMedGoogle Scholar
• Tombaugh TN, Hubley AM. The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years. J Clin Exp Neuropsychol. 1997 Dec;19(6):922–32.
   Google Scholar
• Hartman DE. Wechsler Adult Intelligence Scale IV (WAIS IV): return of the gold standard. Appl Neuropsychol 2009;16:85–87.
   PubMedGoogle Scholar
• Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643–662.
   Google Scholar
• Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol 1998;82:971–973.
   PubMed Web of Science ®Google Scholar
• Murdoch I. People and eyes: statistics in ophthalmology. Community Eye Health J 1998;11:43.
   PubMedGoogle Scholar
• Chiu K, Chan T-F, Wu A, Leung IY-P, So K-F, Chang RC-C. Neurodegeneration of the retina in mouse models of Alzheimer’s disease: what can we learn from the retina? Age 2012;34:633–649.
   PubMed Web of Science ®Google Scholar
• Ascaso FJ, Cruz N, Modrego PJ, Lopez-Anton R, Santabárbara J, Pascual LF, Lobo A, Cristóbal JA. Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study. J Neurol 2014;261:1522–1530.
   PubMed Web of Science ®Google Scholar
• Oktem EO, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 2015;36:1141–1146.
   PubMed Web of Science ®Google Scholar
• Shen Y, Shi Z, Jia R, Zhu Y, Cheng Y, Feng W, Li C. The attenuation of retinal nerve fiber layer thickness and cognitive deterioration. Front Cell Neurosci 2013;7:142.
   Google Scholar
• Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20:6–15.
   Google Scholar
• Frost S, Martins R, Kanagasingam Y. Ocular biomarkers for early detection of Alzheimer’s disease. J Alzheimers Dis 2010;22:1–16.
   PubMed Web of Science ®Google Scholar
• Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA. 2003;289:2094–2103.
   Google Scholar
• Idiaquez J, Alvarez G, Villagra R, San Martin RA. Cholinergic supersensitivity of the iris in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1994;57:1544–1545.
   PubMed Web of Science ®Google Scholar
• Iijima A, Haida M, Ishikawa N, Ueno A, Minamitani H, Shinohara Y. Re-evaluation of tropicamide in the pupillary response test for Alzheimer’s disease. Neurobiol Aging 2003;24:789–796.
   PubMed Web of Science ®Google Scholar
• Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X, Mavros C, Coccia JA, Faget KY, Fitch KA, Masters CL, Tanzi RE, Chylack LT, Bush AI. Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer’s disease. Lancet 2003;361:1258–1265.
   PubMed Web of Science ®Google Scholar
• Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of β-amyloid(1–42) and tau in patients with retinal diseases. Jpn J Ophthalmol 2005;49:106–108.
   PubMed Web of Science ®Google Scholar
• Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 2007;48:2285–2289.
   PubMed Web of Science ®Google Scholar
• Koh VT, Tham Y-C, Cheung CY, Wong W-L, Baskaran M, Saw S-M, Wong TY, Aung T. Determinants of ganglion cell-inner plexiform layer thickness measured by high-definition optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:5853–5859.
   PubMed Web of Science ®Google Scholar
• Mwanza J-C, Durbin MK, Budenz DL, Sayyad FE, Chang RT, Neelakantan A, Godfrey DG, Carter R, Crandall AS. Glaucoma diagnostic accuracy of ganglion cell–inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology 2012;119:1151–1158.
   PubMed Web of Science ®Google Scholar
• Verkhratsky A, Olabarria M, Noristani HN, Yeh C-Y, Rodriguez JJ. Astrocytes in Alzheimer’s disease. Neurotherapeutics 2010;7:399–412.
   PubMed Web of Science ®Google Scholar
• Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, Osborne NN, Reichenbach A. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009;28:423–451.
   PubMed Web of Science ®Google Scholar
• Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol 2007;245:627–636.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 2005;115:2793–2800.
   PubMed Web of Science ®Google Scholar
• Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer’s disease. Prog Retin Eye Res 2011;30:217–238.
   PubMed Web of Science ®Google Scholar